NEWS & EVENTS
Overview
Past Press Releases
Publications
News & Events: Overview

Press Releases

8/11/08 Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM-121, an ErbB3 Antagonist
6/10/08 Merrimack Pharmaceuticals Raises $60 Million in Private Financing
4/24/08 In vivo Safety and Efficacy Data on MM-121, Merrimack's Most Advanced Oncology Product, presented during the Annual Meeting of the American Association for Cancer Research
3/14/08 Merrimack Pharmaceuticals Completes Enrollment in a Phase 2 Study of MM-093 in Patients with Rheumatoid Arthritis
11/29/07 Merrimack Pharmaceuticals Announces the Addition of Robert Gay to its Board of Directors
7/23/07 Merrimack Pharmaceuticals Names William Slichenmyer, MD Senior Vice President & Chief Medical Officer
6/26/07 Merrimack Pharmaceuticals Names Lisa Evrén Senior Vice President & Chief Financial Officer
6/12/07 Merrimack Pharmaceuticals Receives U.S. Patent Covering Composition of Matter for Recombinant, Non-Glycosylated Human Alpha-fetoprotein; Extends Patent Protection of Lead Product, MM-093, into 2025
4/17/07 Merrimack Pharmaceuticals Initiates Enrollment in a Phase 2 Study of MM-093 in Patients with Rheumatoid Arthritis
4/4/07 Merrimack Pharmaceuticals Initiates Enrollment in a Phase 2 Pilot Study of MM-093 in Patients with Autoimmune Uveitis
3/26/07 Merrimack Pharmaceuticals to Present at CIBC Biotechnology and Specialty Pharmaceuticals Conference
1/12/07 Merrimack Pharmaceuticals to Present at BIO CEO Conference
  view past press releases

Upcoming Conferences

January 7-10 , 2008 JPMorgan 26th Annual Healthcare Conference
Location: San Francisco, CA
February 21 - 22, 2008 GTCbio's 5th Annual Cancer Drugs Research and Development Conference
Location: Phoenix, Arizona
March 17 - 20, 2008 Cowen & Company 28th Annual Healthcare Conference
Location: Boston, MA
March 26 - 27, 2008 Molecular Medicine Tri-Conference 2008
Location: San Francisco, CA
April 12-16, 2008 AACR Annual Meeting 2008
Location: San Diego, CA
April 28 - 30, 2008 Bio-IT World Conference & Expo
Location: Boston, MA
April 29, 2008 Mathworks Symposium, Computational Biology '08
Location: Cambridge, MA
June 2 - 4, 2008

IBC BioProcess International Analytical and Quality Summit
Location: Cambridge, MA

June 8 - 11, 2008

Beyond Genome: Appyling Systems Biology
Location: San Francisco, CA

June 12 - 13, 2008 Council on Systems Biology in Boston (CSB2)
Location: Boston, MA
June 22 - 26, 2008 Drug Information Association - 44th Annual Meeting
Location: Boston, MA
July 28 - 30, 2008 WilBio-Single-Use BioProcess Components and Systems
Location: San Francisco, CA
August 4 - 7, 2008 Poster Session - Society of Industrial and Applied Mathematics Conference on Life Sciences
Location: Montreal, Quebec
August 4 - 7, 2008

Drug Discovery & Development of Innovative Therapeutics
Location: Boston, MA

August 6 - 9, 2008

Poster Sessions - The 2nd Annual Q-Bio Conference on Cellular Information Processing
Location: Santa Fe, NM

August 22 - 28, 2008 The 9th International Conference on Systems Biology
Location: Gothenburg, Sweden
September 16 - 21, 2008 Poster Session - Keystone Symposium on Structural Biology and Activation Mechanisms of Membrane Receptors
Location: Cambridge, UK
September 22 - 25, 2008 IBC Lifesciences Conference on Assays & Cellular Targets
Location: San Diego, CA
September 24 - 26, 2008 2008 UBS Global Life Sciences Conference
Location: New York, NY
October 14 - 16, 2008

Oncology Drug Development World Europe 2008
Location: London, UK

November 3 - 4, 2008 Oppenheimer 19th Annual Healthcare Conference
Location: New York, NY
November 18 - 19, 2008 Lazard Capital Markets 5th Annual Healthcare Conference
Location: New York, NY
December 7 - 11, 2008 Antibody Engineering and Immunotherapeutics for the 21st Century
Location: San Diego, CA
March 27 - April 1, 2009

Keystone Symposia Conference: Antibodies as Drugs
Location: Whistler, British Columbia

[ back to top ]

 
             
    > Back to Home
Site Design by Digizyme
 
About Pipeline Research & Development News & Events Careers Contact Merrimack Pharmaceuticals